Our work unraveling cell death pathways (Carneiro and El-Deiry, 2020) as an approach to understand and therapeutically target human cancer led us to discover TRAIL receptor DR5 as a p53 target gene (Wu et al., 1997). The gene discussed is TP53; the disease is cancer.